ATE84213T1 - Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung. - Google Patents

Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung.

Info

Publication number
ATE84213T1
ATE84213T1 AT88118627T AT88118627T ATE84213T1 AT E84213 T1 ATE84213 T1 AT E84213T1 AT 88118627 T AT88118627 T AT 88118627T AT 88118627 T AT88118627 T AT 88118627T AT E84213 T1 ATE84213 T1 AT E84213T1
Authority
AT
Austria
Prior art keywords
soluble polymer
exifon
water soluble
pharmaceutical preparation
preparation containing
Prior art date
Application number
AT88118627T
Other languages
English (en)
Inventor
Yoshio Ueda
Fumio Shimojo
Mitsuru Yasumura
Kenzo Toyoshima
Nobumitsu Nakahashi
Original Assignee
Pharmascience Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmascience Lab filed Critical Pharmascience Lab
Application granted granted Critical
Publication of ATE84213T1 publication Critical patent/ATE84213T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT88118627T 1987-11-11 1988-11-09 Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung. ATE84213T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28449387 1987-11-11
EP88118627A EP0315964B1 (de) 1987-11-11 1988-11-09 Exifon und ein wasserlösliches Polymer enthaltende pharmazeutische Zubereitung

Publications (1)

Publication Number Publication Date
ATE84213T1 true ATE84213T1 (de) 1993-01-15

Family

ID=17679231

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88118627T ATE84213T1 (de) 1987-11-11 1988-11-09 Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung.

Country Status (8)

Country Link
US (1) US5093372A (de)
EP (1) EP0315964B1 (de)
KR (1) KR0132571B1 (de)
AT (1) ATE84213T1 (de)
CA (1) CA1319110C (de)
DE (1) DE3877331T2 (de)
ES (1) ES2043766T3 (de)
PH (1) PH26518A (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640137A1 (fr) * 1988-12-08 1990-06-15 Texinfine Sa Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention
ES2093106T3 (es) * 1990-07-19 1996-12-16 Otsuka Pharma Co Ltd Preparacion solida.
US5977077A (en) * 1995-08-28 1999-11-02 Interlab Corporation Xanthone analogs for the treatment of infectious diseases
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
CN1211928A (zh) * 1996-11-04 1999-03-24 联合碳化化学品及塑料技术公司 提高基本不溶于水的化合物溶解度的方法
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
JP4568426B2 (ja) 1998-04-08 2010-10-27 協和発酵キリン株式会社 錠剤の製造方法及び錠剤
WO2001041773A1 (en) 1999-12-02 2001-06-14 Interlab, Inc. Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins
DZ3227A1 (fr) 1999-12-23 2001-07-05 Pfizer Prod Inc Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
EP1269994A3 (de) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
MXPA03011935A (es) * 2001-06-22 2004-03-26 Pfizer Prod Inc Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco.
US20040224020A1 (en) * 2002-12-18 2004-11-11 Schoenhard Grant L. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2675991C (en) * 2007-01-31 2013-12-24 Asahi Glass Company, Limited Ion exchange membrane for alkaline chloride electrolysis
CN106138018B (zh) * 2015-04-02 2020-03-13 广州洁成生物科技有限公司 羟基二苯甲酮在制备抗病毒和抗肿瘤药物中的应用
KR20180101404A (ko) * 2015-12-17 2018-09-12 메사추세츠 인스티튜트 오브 테크놀로지 폴리히드록실화된 벤조페논의 조성물 및 신경변성 장애의 치료 방법
JP7074677B2 (ja) * 2016-02-16 2022-05-24 シガ・テクノロジーズ・インコーポレーテッド Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤
JP2021532098A (ja) * 2018-07-19 2021-11-25 インペル ニューロファーマ インコーポレイテッド パーキンソン病の治療のためのレボドパおよびドーパデカルボキシラーゼ阻害剤の呼吸管路送達

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1492034A1 (de) * 1965-05-18 1969-02-20 Merck Ag E Verfahren zur Herstellung fester haltbarer Zubereitungen von empfindlichen,in Wasser schwer loeslichen Wirkstoffen,vorzugsweise Arzneimitteln
JPS5439445B2 (de) * 1973-03-24 1979-11-28
FR2257272B1 (de) * 1974-01-15 1978-08-25 Pharmascience Labo
FR2377202A2 (fr) * 1977-01-12 1978-08-11 Pharmascience Lab Compositions pharmaceutiques contenant de l'hexahydroxy-2,3,4,3',4',5'-benzophenone
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition

Also Published As

Publication number Publication date
DE3877331D1 (de) 1993-02-18
PH26518A (en) 1992-08-07
US5093372A (en) 1992-03-03
CA1319110C (en) 1993-06-15
EP0315964B1 (de) 1993-01-07
KR890007722A (ko) 1989-07-05
KR0132571B1 (ko) 1998-04-17
ES2043766T3 (es) 1994-01-01
EP0315964A1 (de) 1989-05-17
DE3877331T2 (de) 1993-05-27

Similar Documents

Publication Publication Date Title
DE3877331D1 (de) Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung.
DE69029006D1 (de) Wasserlösliche hochmolekulare polymere Arzneistoffzubereitung
DE69019817D1 (de) Trägermaterial zur Arzneimittelverabreichung.
DE69006472D1 (en) Zahnärztliche Zusammensetzungen, Verfahren zur Herstellung von geformten, zahnärztlichen Artikeln via "photoiniferte Polymerisation" von zahnärztlichen Zusammensetzungen und dadurch erzeugte geformte, zahnärztliche Artikel.
FI871314A7 (fi) Pinta-aktiivista ainetta sisältävät lääkeaineadsorbaatit ja menetelmä niiden valmistamiseksi.
FR2633181B1 (fr) Composition pharmaceutique a base de ranitidine et son procede de preparation
PT85213A (en) Process for preparing sustained release pharmaceutical compositions in oral dosage form containing a cellulosic polymer
ATA315488A (de) Neue adenosinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate
FI880163L (fi) Menetelmä lääkeaineena käytettävän liuoksen valmistamiseksi
DE68900994D1 (de) Diphosphonsaeurederivat enthaltendes arzneimittel zur oralen gabe.
ATE179887T1 (de) Arzneimittelzubereitung
FI874660A7 (fi) Aine hammasjäljennöksiä varten.
FI871313A7 (fi) Menetelmä lääkeadsorbaattien valmistamiseksi.
LTIP1851A (en) Process for preparing bioerodible polymer, said polymer, bioerodible pharmaceutical composition, process for preparing thereof
PH25286A (en) Sustained release drug preparation
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
DE3677842D1 (de) Verfahren zur herstellung von piperidyliden-dihydrodibenzo(a,d)zykloheptenen und deren azoderivate, so hergestellte verbindungen und ihre anwendung zur vorbereitung von heilmitteln.
EP0448091A3 (en) Pharmaceutical composition containing slightly water-soluble drug
DE69007714D1 (de) Pharmazeutische Zubereitung mit antitumoraler Wirkung und Verfahren zur Herstellung.
DE3674582D1 (de) (s)-(-)-1-propyl-2',6'-pipecoloxylidid-hydrochloridmonohydrat, verfahren zu seiner herstellung und es enthaltendes pharmazeutisches praeparat.
FI875719A7 (fi) Uudet alkaanisulfonanilidijohdokset, menetelmä niiden valmistamiseksi ja näitä sisältävät farmaseuttiset seokset.
DE69012650D1 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
DE3852332D1 (de) 4-Thiochinazolin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammenstellungen.
DK0443848T3 (da) Nyt antiulcermiddel
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee